- 2 hours ago
Genetic medicines expert Emily Walsh Martin shares learnings from Day 2 of #ASGCT2024
- 1 day ago
SalioGen’s CEO on the company’s ‘Gene Coding’ approach to genetic medicine and an oral presentation today at #ASGCT2024 for its Stargardt disease program
- 1 day ago
Previewing the 2024 ASGCT Annual Meeting in Baltimore with gene editing expert TJ Cradick
- 2 days ago
A computational biologist and assistant professor at Philadelphia’s Wistar Institute on positives and potential negatives of AI’s emergence to the forefront of life sciences
- 3 days ago
Founder Mark Kotter describes the science that has enabled bit.bio to design and manufacture virtually any cell type and characteristic from iPSCs
- 3 days ago
Ochre Bio CEO Jack O'Meara discusses his company's focus on liver diseases and its recent Boehringer Ingelheim partnership